Southland Equity Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
2,755
+161
+6% +$13K 0.04% 288
2026
Q1
$225K Buy
2,594
+79
+3% +$7.57K 0.04% 247
2025
Q4
$242K Buy
2,515
+8
+0.3% +$777 0.05% 225
2025
Q3
$239K Buy
2,507
+91
+4% +$8.37K 0.05% 216
2025
Q2
$211K Buy
+2,416
New +$205K 0.05% 229

Other funds holding MDT

Southland Equity Partners's MDT Position: Q2 2026 in Review

Southland Equity Partners increased its Medtronic (MDT) stake by 6.2% in Q2 2026, buying an estimated $13K and bringing the position to 2,755 shares worth $215K. The position accounts for 0.04% of the portfolio, ranked #288.

Southland Equity Partners first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. The position peaked at $242K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Southland Equity Partners held 2,755 shares of Medtronic worth $215K as of Q2 2026.
  • Southland Equity Partners bought 161 Medtronic shares in Q2 2026, an estimated $13K.
  • Medtronic made up 0.04% of Southland Equity Partners's portfolio in Q2 2026, its #288 holding.
  • Southland Equity Partners first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • Southland Equity Partners's Medtronic position peaked at $242K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.